Results 291 to 300 of about 232,884 (341)
Hypertension and its complications in a young man with autoimmune disease [PDF]
Basile, Jan N.+9 more
core +1 more source
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews+3 more
wiley +1 more source
Oxidized LDL enhances Gq signaling and aldosterone production by angiotensin II via the AT1-LOX-1 receptor complex in adrenal cells. [PDF]
Ihara J+16 more
europepmc +1 more source
Studies on Renal Aldosterone-binding Proteins
T S Herman, G M Fimognari, I. S. Edelman
openalex +1 more source
ABSTRACT Objective We quantified the magnitude of systolic blood pressure (SBP) adverse effects associated with intravenous furosemide (IVFu), compared to other factors, during treatment for acute decompensated heart failure (ADHF). Methods Continuous BP monitoring (598.2 person‐hours, 91,210 observations) before and after IVFu was performed in a ...
Nicholas E. Harrison+7 more
wiley +1 more source
Aldosterone Secretory Rates in the Normal Menstrual Cycle
M. J. Gray+4 more
openalex +1 more source
In a pooled analysis, bradycardia was observed in 6% of terlipressin‐treated patients but rarely required a dose interruption or reduction. Arrhythmia serious adverse event incidences were low and similar in both treatment groups. Routine intensive cardiac monitoring for the detection of arrhythmias may not be necessary during terlipressin ...
Jasmohan S. Bajaj+6 more
wiley +1 more source
Establishment and evaluation of a patient-derived organoids-based xenograft model of primary aldosteronism using [<sup>18</sup>F]AlF-NOTA-pentixather PET/CT: bridging preclinical and clinical imaging. [PDF]
Zhang X+12 more
europepmc +1 more source
Metabolic Requirements for Active Sodium Transport Stimulated by Aldosterone
Geoffrey W.G. Sharp, Alexander Leaf
openalex +1 more source
Background and purpose Diabetic nephropathy (DN) is a common complication of diabetes. Current treatments include renin‐angiotensin‐aldosterone system (RAAS) blockers and sodium‐glucose co‐transporter 2 (SGLT2) inhibitors. The cannabinoid CB1 receptor is a potential therapeutic target.
Océane Pointeau+20 more
wiley +1 more source